These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 37109144
1. Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis. Sierra L, Barba R, Ferrigno B, Goyes D, Diaz W, Patwardhan VR, Saberi B, Bonder A. J Clin Med; 2023 Apr 11; 12(8):. PubMed ID: 37109144 [Abstract] [Full Text] [Related]
2. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients. Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM. Liver Transpl; 2016 Sep 11; 22(9):1214-22. PubMed ID: 27339253 [Abstract] [Full Text] [Related]
3. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M. J Gastrointest Surg; 2009 Aug 11; 13(8):1480-6. PubMed ID: 19430850 [Abstract] [Full Text] [Related]
4. Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations. Medina-Morales E, Ismail M, Barba Bernal R, Abboud Y, Sierra L, Marenco-Flores A, Goyes D, Saberi B, Patwardhan V, Bonder A. J Clin Med; 2023 Oct 15; 12(20):. PubMed ID: 37892674 [Abstract] [Full Text] [Related]
5. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE. Hepatology; 2011 Oct 15; 54(4):1313-21. PubMed ID: 21688284 [Abstract] [Full Text] [Related]
6. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30. Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S. Liver Transpl; 2021 Jul 15; 27(7):971-983. PubMed ID: 33492764 [Abstract] [Full Text] [Related]
7. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India. Jadaun SS, Mehtani R, Hasnain A, Bhatia S, Moond V, Kumar M, Kuhad V, Singh S, Agarwal S, Gupta S, Saigal S. Hepatol Int; 2023 Apr 15; 17(2):499-506. PubMed ID: 36376772 [Abstract] [Full Text] [Related]
8. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database. Kashyap R, Safadjou S, Chen R, Mantry P, Sharma R, Patil V, Maloo M, Ryan C, Marroquin C, Barry C, Ramaraju G, Maliakkal B, Orloff M. J Gastrointest Surg; 2010 Sep 15; 14(9):1362-9. PubMed ID: 20617395 [Abstract] [Full Text] [Related]
9. Liver Transplantation: East versus West. Shukla A, Vadeyar H, Rela M, Shah S. J Clin Exp Hepatol; 2013 Sep 15; 3(3):243-53. PubMed ID: 25755506 [Abstract] [Full Text] [Related]
10. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562 [Abstract] [Full Text] [Related]
11. Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Goldberg DS, French B, Abt PL, Olthoff K, Shaked A. Hepatology; 2014 Nov 15; 60(5):1717-26. PubMed ID: 25042283 [Abstract] [Full Text] [Related]
12. Defining long-term outcomes with living donor liver transplantation in North America. Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A. Ann Surg; 2015 Sep 15; 262(3):465-75; discussion 473-5. PubMed ID: 26258315 [Abstract] [Full Text] [Related]
13. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation. Choudhary NS, Saigal S, Thummala S, Saraf N, Rastogi A, Bhangui P, Srinivasan T, Yadav SK, Nundy S, Soin AS. J Clin Exp Hepatol; 2020 Sep 15; 10(5):442-447. PubMed ID: 33029052 [Abstract] [Full Text] [Related]
14. Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants. Sandal S, Almudevar A, Parajuli S, Bose A. Clin Transplant; 2015 Dec 15; 29(12):1140-7. PubMed ID: 26383173 [Abstract] [Full Text] [Related]
15. Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. Sierra L, Marenco-Flores A, Barba R, Goyes D, Ferrigno B, Diaz W, Medina-Morales E, Saberi B, Patwardhan VR, Bonder A. Ann Hepatol; 2024 Dec 15; 29(3):101283. PubMed ID: 38151060 [Abstract] [Full Text] [Related]
16. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group. Liver Transpl; 2007 Jan 15; 13(1):122-9. PubMed ID: 17192908 [Abstract] [Full Text] [Related]
17. Recipient Survival among Living Donor vs. Deceased Donor Liver Transplants for Acute Liver Failure in the United States. Moughames E, Gurakar M, Khan A, Alsaqa M, Ozturk NB, Bonder A, Gurakar A, Saberi B. J Clin Med; 2024 Mar 17; 13(6):. PubMed ID: 38541954 [Abstract] [Full Text] [Related]
18. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up. Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS. Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468 [Abstract] [Full Text] [Related]
19. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry. Taniguchi M. Clin Transpl; 2012 Aug 27; ():41-65. PubMed ID: 23721009 [Abstract] [Full Text] [Related]
20. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry. Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, Heneghan MA, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Mehrabi A, Acarli K, Tokat Y, Coker A, Yilmaz S, Karam V, Duvoux C, Lohse AW, Schramm C, all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA). Am J Transplant; 2022 Feb 27; 22(2):626-633. PubMed ID: 34605157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]